In ovarian cancer, Tspan29 expression levels correlated with integrins β1, α2, α3, α5, and α6, and downregulation of Tspan29 expression resulted in diminished stromal adhesion and diffuse growth [35]. This evidence concerns the gene CD9 and ovarian carcinoma.